Navigation Links
Novel medication improves ovarian cancer treatment
Date:10/31/2007

Newport Beach, Calif. October 31, 2007 A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.

Ovarian cancer is the fifth most common cancer in women, accounting for nearly 14,000 deaths annually in the United States. Despite the use of chemotherapy treatment, nearly 70 percent of all ovarian cancer patients will eventually succumb to their disease. Consequently, studies have continued to investigate the activity of novel medications in combination with standard therapy to improve overall and disease-free survival in ovarian cancer patients.

Bevacizumab has been studied clinically and was recently approved as a treatment for metastatic colon cancer and non-small cell lung cancer. Currently, Bevacizumab is also being studied as a treatment to improve patient survival rates for breast and kidney cancers. Since Bevacizumab has a unique mechanism of action and a favorable safety profile, the medication is not associated with unreasonable levels of toxicity. However, previous studies have reported that gastro-intestinal perforations and hypertension may be a consequence of treatment involving Bevacizumab. The results from our research suggest that the combination of Bevacizumab and standard therapy for the treatment of ovarian cancer may be promising, particularly with regard to safety and efficacy, says Dr. Bram Goldstein, co-author of the study.


'/>"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Gene enchances radiation therapy - A novel approach to fight cancer
3. A novel augmentation
4. Novel biopsy technique for prostate cancer
5. Novel computer model for breast cancer
6. Novel research on liver cancer
7. Novel way to fight cancer
8. Novel test for bowel cancer
9. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
10. Novel Therapy for Chronic Problem
11. Blood Sugar Kept In Control By Novel Protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...bad cholesterol more effectively than Zocor , ... nearly a year of review, U.S. health officials sa...of the controversial cholesterol-lowering drug Vyt...aid there was no significant difference in carotid...and patients taking the drug Zocor. , But, the ...
(Date:1/8/2009).... 8 Hanger Orthopedic Gr...at throughout the fourth quarter of 2008 it acquir...cky Mountain Orthotic-Prosthetics Center, Riessen,...Coast Orthotics & Prosthetics, and Orthopedic ...dd patient care centers to existing markets in Mai...
(Date:1/8/2009)...Jan. 8 Medivation, Inc.,..., M.D., president and chief,executive officer, wi...re,Conference on Wednesday, January 14, at 10:00 ... in San Francisco. , Dr. Hung will provide ...pment programs for Dimebon for Alzheimer,s and Hun...
(Date:1/8/2009).... 8 A new educational W...dance on drugs, biological products and medical de...Quality,s Centers for Education and Research on Th...of more than a dozen leading research centers nati...formation Network ( CHAIN ) http://www.chainonlin...
Breaking Medicine News(10 mins):Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2
...at should be welcome news for tens of thousands of...ing homes are modernising and entering into tie-up... the growing trend in medical tourism. Half a doz...e up in a year, in addition to scores of smaller g...
...mical component extracted from the cannabis, or ma...ach cramping after eating, according to a study pr... the American College of Gastroenterology. The stu...and placebo on colonic motility and sensation in h...
...rs working in Iraq admit that more than half of th... medical equipment and more experienced staff and ...sim Al Sheibani and colleagues say that as the vio...y is that they cannot treat many of the victims. ...
...ding to the researchers in the U.S., a supplement ...ction of stress linked to metabolic syndrome, a co... diabetes and heart disease. Metabolic syndrome c...on, and unstable glucose and insulin metabolism an...
Other Medicine News:Health News:Agra Hospitals Modernise to Promote Medical Tourism 2Health News:Cinnamon extract in reduction of risk of metabolic syndrome 2
(Date:1/6/2009)...r maintaining a healthy immune system , , PURCH...shed study in Nutrition and Cancer (60(5), 643-6... Osaka, Japan has shown that AHCC (Active Hexose C...creasing the number of dendritic cells (DCs). DCs ...r presenting foreign substances to other immune sy...
(Date:1/6/2009)...wswire/ -- Cequent Pharmaceuticals, a pioneer in t...ased treatments to prevent and treat human disease...d a successful toxicology study of its candidate C... targeting the primary oncogene (beta-catenin, CTN...is an inherited gastrointestinal disease that caus...
(Date:1/5/2009)...ewswire-FirstCall/ -- Micromet, Inc.,(Nasdaq: M...l, proprietary,antibodies for the treatment of ca...des an outlook on key events anticipated for the y...n update on its research and development,programs...16, 2009: Update on several preclinical BiTE antib...
(Date:12/29/2008)...wire-USNewswire/ -- The winner of the 2008 Award f...ounced today by Dr. Peter G. Goldschmidt, Presiden... , , The winner of the annual award was the ...-- for its best practice " IND Regulatory and Mo...nhanced human subjects protection, 2) improved dat...
Breaking Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2Depressed Moms Kids at Higher Injury Risk 7613 1Depressed Moms Kids at Higher Injury Risk 7613 2Fry Construction Is Featured in Key Industry Publication 7610 1Fry Construction Is Featured in Key Industry Publication 7610 2InvoiceCHECK Cuts Prescription Benefit Waste 7606 1InvoiceCHECK Cuts Prescription Benefit Waste 7606 2DenteMax Forms Business Alliance With MEDILINQ 7602 1DenteMax Forms Business Alliance With MEDILINQ 7602 2
...lood Pressure in Obese and,Non-Obese Hypertensive ...all/ -- Forest,Laboratories, Inc. today presented ...oled analysis of nebivolol, a selective beta,1-blo...review by,the U.S. Food and Drug Administration (F...he two clinical studies show that,nebivolol demons...
... and 40/25 mg/day and Amlodipine +,Benazepril 5/20...,Hypertension Twenty-Second Annual Scientific Meet...- New data,presented today at the American Society... Meeting (ASH 2007) in Chicago,demonstrated that t...medoxomil/hydrochlorothiazide) was associated with...
Other Medicine Technology:Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 2Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 3Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8
...tome Semi-Automatic Tissue Sectioning System has m...ctioning system. Researchers from around the globe...ir fresh and fresh fixed tissue sectioning needs f...issue Sectioning Systems, the biological viability...
...3000 Deluxe Sectioning System provides a versatile...ant tissues. The 3000 employs a vibrating blade p...or embedding. The creation of artifacts, the alte...tivities, and other deleterious effect inherent in...
The Vibratome comes standard with a square vice mounting device. These specimen blocks are utilized for mounting specimens and placing in the Vibratome holding vice. The blocks are annodized black
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades.
Medicine Products: